Chemed (CHE) Current Deferred Tax Assets (2009 - 2017)

Chemed's Current Deferred Tax Assets history runs 9 years deep, the most recent figure standing at $21.9 million for Q3 2017.

• In Q3 2017, Current Deferred Tax Assets changed N/A year-over-year to $21.9 million; the TTM figure through Sep 2017 stood at $21.9 million (changed N/A YoY), while the FY2016 annual figure was $8000.0, changed N/A from the prior year.
• Current Deferred Tax Assets was $21.9 million for Q3 2017 at Chemed, up from $20.6 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $25.1 million in Q3 2013 to a low of $8000.0 in Q4 2016.
• Historically, Current Deferred Tax Assets has averaged $16.4 million across 5 years, with a median of $16.7 million in 2015.
• The sharpest annual moves came in 2013 and 2014: Current Deferred Tax Assets soared 77.79% in 2013, then plunged 42.06% in 2014.
• A 5-year view of Current Deferred Tax Assets shows it stood at $20.3 million in 2013, then retreated by 23.91% to $15.4 million in 2014, then grew by 12.38% to $17.3 million in 2015, then sank by 99.95% to $8000.0 in 2016, then surged by 273562.5% to $21.9 million in 2017.
• The last three Current Deferred Tax Assets figures came in at $21.9 million (Q3 2017), $20.6 million (Q2 2017), and $8000.0 (Q4 2016), per Business Quant data.